⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

Characterizing the Effects of Progranulin Reduction on Tau Pathology and Phenotypes in a Mouse Model of Tauopathy (P4-9.016)

Sanaea Bhagwagar Hideyuki Takahashi Stephen M. Strittmatter

View Full Paper

Ask AI

Bookmark

Share

Abstract

To characterize how progranulin (PGRN) reduction affects tau pathology and tau-dependent phenotypes in tau transgenic mice with either PGRN haploinsufficiency or complete absence.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bhagwagar et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db64358767816d https://doi.org/10.1212/wnl.0000000000205227

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase2024 · 31 citations
2Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient miceOriginal Research · 2026 · 1 citations
3Aging is associated with behavioral alterations, lysosomal dysfunction, region-specific inflammation, and glutamatergic synaptic impairments in a Grn knockout mouse model of frontotemporal dementiaOriginal Research · 2026
4Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration2024 · 29 citations
5Ablation of progranulin augments microglial activation and accelerates prion progression2025